| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Svp-chief Financial Officer
1 company
Maxwell John T. is a Svp-chief Financial Officer at Aquestive Therapeutics, Inc.. Recent SEC Form 4 filings include 2 buys and 1 sell.
Estimated insider holdings value: $709K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2020 | AQST Aquestive Therapeutics, Inc. | Svp-chief Financial Officer | Sell | 3,000 | $8.00 | $24,000.00 | -2.0% | |
| Dec 6, 2018 | AQST Aquestive Therapeutics, Inc. | Svp-chief Financial Officer | Buy | 5,000 | $8.87 | $44,350.00 | +3.4% | |
| Nov 21, 2018 | AQST Aquestive Therapeutics, Inc. | Svp-chief Financial Officer | Buy | 10,000 | $9.80 | $98,000.00 | +7.2% |